Correction to: _Molecular Psychiatry_ (2020) 25:1477-1486 https://doi.org/10.1038/s41380-019-0395-3 Published online 19 March 2019 Following publication of this article, the authors became

aware of an error regarding the effect alleles for genetic variants associated with circulating interleukin 6 (IL-6). The effect alleles for genetic variants associated with circulating

interleukin 6 (IL-6) were misaligned due to an error propagated from a previous publication in which the minor allele of the IL6R variant rs7529229 was incorrectly labelled as the T allele

[1]. Based on this error, effect alleles for three variants in the IL6R gene region require correction, which leads to changes in Supplementary Table 6, and Mendelian randomization estimates

genetically-predicted log-transformed CRP was 1.18 (95% CI 1.07–1.29; _p_ = 0.0009).” was changed to: “The odds ratio for depression per standard deviation increase in genetically-predicted

triglycerides was 1.18 (95% CI 1.09–1.27; _p_ = 2 × 10−5); per unit increase in genetically-predicted log-transformed IL-6 was 1.35 (95% CI 1.12–1.62; _p_ = 0.0012); and per unit increase

in genetically-predicted log-transformed CRP was 1.18 (95% CI 1.07–1.29; _p_ = 0.0009).” 2. In the “Results” section, under the heading “Mendelian randomization analyses”: “For the

inflammatory biomarkers (Table 3), there was an evidence for causal effects of IL-6 and CRP, with an odds ratio of 0.74 (95% CI: 0.62–0.89, _p_ = 0.0012) per unit increase in

genetically-predicted values of log-transformed IL-6 (Fig. 1b)…” was changed to: “For the inflammatory biomarkers (Table 3), there was evidence for causal effects of IL-6 and CRP, with an

odds ratio of 1.35 (95% CI 1.12–1.62; _p_ = 0.0012) per unit increase in genetically-predicted values of log-transformed IL-6 (Fig. 1b)…” Additionally, in this section: “Although these

results appear to be in different directions, variants in the IL6R gene region affect cellular binding of interleukin-6 receptor (IL-6R). Increased circulating concentrations of IL-6 do not

represent increased production of IL-6, but rather reduced cellular binding [37]. Hence for both inflammatory markers, increased levels of the inflammatory marker lead to greater risk of

depression.” was changed to: “The alleles associated with increased IL-6 levels are also associated with decreased CRP levels. This provides a discrepancy in the interpretation of results

based on variants in the IL6R and CRP gene regions: variants in the CRP gene region associated with increased CRP levels were associated with increased risk of depression, whereas variants

in the IL6R gene region associated with increased circulating IL-6 levels but decreased IL-6 activity and decreased CRP levels were associated with increased risk of depression. Further

investigation is needed to understand this discrepancy, which could be linked to divergent effects of IL-6 classical and trans signalling on depression risk, and/or CRP-dependent vs

CRP-independent effects of IL-6 on depression risk.” 3. In Table 3, in the row IL-6, the odds ratio (95% CI) was changed from “0.74 (0.62–0.89)” to “1.35 (1.12–1.62)”. 4. Figure 1b has been

corrected. In the corrected figure, for each of the three variants in the IL6R gene region considered, the allele associated with increased circulating IL-6 concentrations is also associated

with increased risk of depression. The correct Mendelian randomization estimate based on these genetic variants is an odds ratio of 1.35 (95% confidence interval 1.12–1.62, _p_ = 0.0012)

for depression per unit increase in log-transformed circulating levels of IL-6. The original, incorrect version of Fig. 1 is displayed below for reference. 5. The supplementary file has been

replaced. The changes made to this file are as follows: In supplementary Table 6, the effect alleles for IL-6 biomarkers were corrected from “T, T, T”, to “C, C, G”. In Supplementary Table

9, the odds ratio (95% CI) for IL-6 was changed from “0.74 (0.58 to 0.93)”, to “1.36 (1.07 to 1.72)”. In Supplementary Table 10, the odds ratio (95% CI) for IL-6 was changed from “0.76

(0.58–1.00)”, to “1.32 (1.00–1.74)”. The overall finding from the manuscript abstract that “IL-6, CRP and triglycerides, are likely to be causally linked with depression, so could be targets

for treatment and prevention of depression” remains true, even though the direction of estimate for IL-6 was incorrect. The _p_-values for the associations of genetically-predicted IL-6

with depression remain unchanged. This has been corrected in both the PDF and HTML versions of the article. REFERENCE * IL6R MR Consortium. The interleukin-6 receptor as a target for

prevention of coronary heart disease: a Mendelian randomisation analysis. Lancet. 2012;379:1214–24. Article  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS *

Department of Psychiatry, University of Cambridge, Cambridge, UK Golam M. Khandaker & Peter B. Jones * Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK Golam M.

Khandaker * MRC Biostatistics Unit, University of Cambridge, Cambridge, UK Verena Zuber, Christopher N. Foley, Apostolos Gkatzionis & Stephen Burgess * Cardiovascular Epidemiology Unit,

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Jessica M. B. Rees, Amy M. Mason & Stephen Burgess * Department of Clinical Pharmacology, Queen Mary

University of London, London, UK Livia Carvalho Authors * Golam M. Khandaker View author publications You can also search for this author inPubMed Google Scholar * Verena Zuber View author

publications You can also search for this author inPubMed Google Scholar * Jessica M. B. Rees View author publications You can also search for this author inPubMed Google Scholar * Livia

Carvalho View author publications You can also search for this author inPubMed Google Scholar * Amy M. Mason View author publications You can also search for this author inPubMed Google

Scholar * Christopher N. Foley View author publications You can also search for this author inPubMed Google Scholar * Apostolos Gkatzionis View author publications You can also search for

this author inPubMed Google Scholar * Peter B. Jones View author publications You can also search for this author inPubMed Google Scholar * Stephen Burgess View author publications You can

also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Stephen Burgess. RIGHTS AND PERMISSIONS This article is licensed under a Creative Commons

Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original

author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the

article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your

intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence,

visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Khandaker, G.M., Zuber, V., Rees, J.M.B. _et al._ Correction: Shared

mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort. _Mol Psychiatry_ 26, 3659–3661 (2021).

https://doi.org/10.1038/s41380-020-0857-7 Download citation * Published: 17 August 2020 * Issue Date: July 2021 * DOI: https://doi.org/10.1038/s41380-020-0857-7 SHARE THIS ARTICLE Anyone you

share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the

Springer Nature SharedIt content-sharing initiative